Efficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistance
2014 · Epilepsy & Behavior · 9 citations
https://doi.org/10.1016/j.yebeh.2014.09.061
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
97
Citations
5
h-index
3
i10-index
Bob Anders is an academic researcher from Upsher-Smith Laboratories (United States). The author has contributed to research in topics: Epilepsy research and treatment & Pharmacological Effects and Toxicity Studies & Pharmaceutical studies and practices. The author has an h-index of 5, co-authored 17 publications.
Click to start Chat